25-hydroxycholesterol has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alejo, A; Birukov, KG; Birukova, AA; Fessler, MB; Karmaus, PW; Li, Y; Madenspacher, JH; McDonald, JG; Meacham, JM; Mikacenic, C; Morrell, ED; Rai, P; Stapleton, RD; Thompson, BM; Wurfel, MM | 1 |
| Han, Y; Liu, C; Ouyang, W; Wang, S; Xia, J; Xu, F; Zhou, H | 1 |
2 other study(ies) available for 25-hydroxycholesterol and Lung Injury, Acute
| Article | Year |
|---|---|
25-Hydroxycholesterol exacerbates vascular leak during acute lung injury.
Topics: Acute Lung Injury; Animals; Hydroxycholesterols; Macrophages, Alveolar; Mice | 2023 |
25-Hydroxycholesterol protects against acute lung injury via targeting MD-2.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Humans; Hydroxycholesterols; Inflammation; Lipopolysaccharides; Lung; Lymphocyte Antigen 96; Mice; NF-kappa B; Protective Agents; RAW 264.7 Cells; Signal Transduction; Toll-Like Receptor 4 | 2018 |